Companies conducting Clinical Trials in Australia may be eligible for Australia’s Research & Development (R&D) Incentive Scheme.
Australia is up to 25% cheaper than the U.S. before incentives, and 60% cheaper after incentives, with refunds of up to USD 45c in every USD $1 spent in R&D.
Benefits under Australia’s R&D Incentive scheme include:
Eligibility for the R&D Incentive scheme is assessed by the Australian Taxation Office (ATO).
You can only claim an R&D Tax Incentive scheme if you are an R&D entity. Learn more about eligibility requirements on the ATO website.